Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models by Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, Diana Drago‐Garcia, Roni Oren, Mary Luz Uribe, Nishanth Belugali Nataraj, Soma Ghosh, Raya Eilam, Tomer‐Meir Salame, Moshit Lindzen, Yosef Yarden

Get full text

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma by Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer-Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M. Melnick, Wendy Béguelin, Guy Ron, Efrat Shema

Get full text

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma. by Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer-Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M Melnick, Wendy Béguelin, Guy Ron, Efrat Shema

Get full text

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors by Maicol Mancini, Hilah Gal, Nadège Gaborit, Luigi Mazzeo, Donatella Romaniello, Tomer Meir Salame, Moshit Lindzen, Georg Mahlknecht, Yehoshua Enuka, Dominick GA Burton, Lee Roth, Ashish Noronha, Ilaria Marrocco, Dan Adreka, Raya Eilam Altstadter, Emilie Bousquet, Julian Downward, Antonio Maraver, Valery Krizhanovsky, Yosef Yarden

Get full text

Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer’s disease by Javier María Peralta Ramos, Giulia Castellani, Denise Kviatcovsky, Tommaso Croese, Afroditi Tsitsou-Kampeli, Chiara Burgaletto, Miguel Angel Abellanas, Liora Cahalon, Sarah Phoebeluc Colaiuta, Tomer-Meir Salame, Yael Kuperman, Alon Savidor, Maxim Itkin, Sergey Malitsky, Sharon Ovadia, Shir Ferrera, Limor Kalfon, Shiran Kadmani, Nadra Samra, Rotem Paz, Lior Rokach, Roberto Furlan, Judith Aharon-Peretz, Tzipora C. Falik-Zaccai, Michal Schwartz

Get full text